Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.
NCT01282840 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 676
Last updated 2019-01-15
Summary
Overactive bladder syndrome (OAB) affects around 17 % of female population. However, the etiology of OAB is complicated and unclear in many aspects. Bladder wall thickness had been reported to be strongly associated with OAB, but its use as a screening tool remains controversial. Besides, few studies reported patterns of sexual dysfunction in female patients with lower urinary tract symptoms (LUTS). Therefore the aims of our study were to analyze the bladder wall blood perfusion pattern in female LUTS patients, the association of between the bladder wall blood perfusion pattern and the efficacy of anti-muscarinic treatment for female OAB, and the patterns of sexual dysfunction in the female LUTS patients.
Conditions
- Lower Urinary Tract Symptoms
Interventions
- DRUG
-
Tolterodine SR
Tolterodine SR 4 mg qd
Sponsors & Collaborators
-
National Science and Technology Council, Taiwan
collaborator OTHER_GOV -
Far Eastern Memorial Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 99 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-07-20
- Primary Completion
- 2018-11-05
- Completion
- 2018-12-26
Countries
- Taiwan
Study Locations
More Related Trials
-
Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy
NCT07337252 ·Status: COMPLETED
-
Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes
NCT07025642 ·Status: RECRUITING ·Phase: NA
-
Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing
NCT01819168 ·Status: COMPLETED
-
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4
-
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome
NCT01824420 ·Status: COMPLETED ·Phase: PHASE4
-
Sexual Function Trial of Overactive Bladder: Medication Versus PTNS
NCT03500146 ·Status: COMPLETED
-
Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin
NCT04023253 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study
NCT05946902 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)
NCT01533597 ·Status: COMPLETED ·Phase: PHASE4
-
Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome
NCT05040984 ·Status: UNKNOWN
-
Bladder Diary for Diagnosing Bladder Oversensitivity
NCT04981015 ·Status: COMPLETED
-
Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity
NCT00648310 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients
NCT01876186 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder
NCT00137397 ·Status: COMPLETED ·Phase: PHASE4
-
A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder
NCT03566134 ·Status: COMPLETED ·Phase: PHASE2
-
Predictors for Retreatement of OAB After DC Mirabegron
NCT04550702 ·Status: COMPLETED
-
Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder
NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder
NCT00836381 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
NCT02485067 ·Status: COMPLETED ·Phase: PHASE3
-
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
NCT01729819 ·Status: COMPLETED ·Phase: PHASE2
-
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
NCT03572231 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring
NCT00646880 ·Status: COMPLETED ·Phase: PHASE3
-
Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study
NCT04412876 ·Status: WITHDRAWN ·Phase: PHASE3
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN